These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 8799424)
1. Prophylaxis of thromboembolic disease with RO-11 (ROVI), during abdominal surgery. EMRO1 (Grupo Fstudio Multicintrico RO-11). Moreno Gonzalez E; Fontcuberta J; de la Llama F Hepatogastroenterology; 1996; 43(9):744-7. PubMed ID: 8799424 [TBL] [Abstract][Full Text] [Related]
2. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group. Kakkar VV; Howes J; Sharma V; Kadziola Z Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310 [TBL] [Abstract][Full Text] [Related]
3. Low molecular weight heparin and prevention of postoperative thrombosis in abdominal surgery. Koppenhagen K; Adolf J; Matthes M; Tröster E; Roder JD; Hass S; Fritsche HM; Wolf H Thromb Haemost; 1992 Jun; 67(6):627-30. PubMed ID: 1324534 [TBL] [Abstract][Full Text] [Related]
4. Comparison of 3,000 IU aXa of the low molecular weight heparin certoparin with 5,000 IU aXa in prevention of deep vein thrombosis after total hip replacement. German Thrombosis Study Group. Adolf J; Fritsche HM; Haas S; Hennig FF; Horbach T; Kastl S; Koppenhagen K; Michaelis HC; Rhamanzadeh R; Summa W; Wagner W; Weber U; Wolf H Int Angiol; 1999 Jun; 18(2):122-6. PubMed ID: 10424367 [TBL] [Abstract][Full Text] [Related]
5. A randomized double-blind study between a low molecular weight heparin Kabi 2165 and standard heparin in the prevention of deep vein thrombosis in general surgery. A French multicenter trial. Caen JP Thromb Haemost; 1988 Apr; 59(2):216-20. PubMed ID: 2838923 [TBL] [Abstract][Full Text] [Related]
6. Prevention of fatal pulmonary embolism and mortality in surgical patients: a randomized double-blind comparison of LMWH with unfractionated heparin. Haas S; Wolf H; Kakkar AK; Fareed J; Encke A Thromb Haemost; 2005 Oct; 94(4):814-9. PubMed ID: 16270636 [TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population. Ugaki H; Enomoto T; Fujiwara K; Kimura T; Kawasaki T Blood Coagul Fibrinolysis; 2008 Sep; 19(6):585-9. PubMed ID: 18685443 [TBL] [Abstract][Full Text] [Related]
8. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial). Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J; Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738 [TBL] [Abstract][Full Text] [Related]
9. [Thromboembolism prophylaxis with low molecular weight heparin in abdominal surgery]. Adolf J; Knee H; Roder JD; van de Flierdt E; Siewert JR Dtsch Med Wochenschr; 1989 Jan; 114(2):48-53. PubMed ID: 2535983 [TBL] [Abstract][Full Text] [Related]
11. Prevention of postoperative thromboembolism with Enoxaparin in general surgery: a German multicenter trial. Haas S; Flosbach CW Semin Thromb Hemost; 1993; 19 Suppl 1():164-73. PubMed ID: 8395721 [TBL] [Abstract][Full Text] [Related]
12. A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke. Sandset PM; Dahl T; Stiris M; Rostad B; Scheel B; Abildgaard U Semin Thromb Hemost; 1990 Oct; 16 Suppl():25-33. PubMed ID: 1962901 [TBL] [Abstract][Full Text] [Related]
13. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]. Míka P; Behounek J; Skoták M; Nevsímal L Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102 [TBL] [Abstract][Full Text] [Related]
14. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group. Bergmann JF; Neuhart E Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991 [TBL] [Abstract][Full Text] [Related]
15. Low molecular weight heparin for deep vein thrombosis in glioma patients. Schmidt F; Faul C; Dichgans J; Weller M J Neurol; 2002 Oct; 249(10):1409-12. PubMed ID: 12382158 [TBL] [Abstract][Full Text] [Related]
16. Prevention of postoperative deep vein thrombosis in cancer patients. A randomized trial with low molecular weight heparin (CY 216). Marassi A; Balzano G; Mari G; D'Angelo SV; Della Valle P; Di Carlo V; D'Angelo A Int Surg; 1993; 78(2):166-70. PubMed ID: 8394842 [TBL] [Abstract][Full Text] [Related]
17. United States trial of dihydroergotamine and heparin prophylaxis of deep vein thrombosis. DiSerio FJ; Sasahara AA Am J Surg; 1985 Oct; 150(4A):25-32. PubMed ID: 3901790 [TBL] [Abstract][Full Text] [Related]
18. An international multicentre study: Clivarin in the prevention of venous thromboembolism in patients undergoing general surgery. Report of the International Clivarin Assessment Group. Boneu B Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S21-2. PubMed ID: 8180325 [TBL] [Abstract][Full Text] [Related]
19. [Prevention of thrombosis in gynecology: double-blind comparison of low molecular weight heparin and unfractionated heparin]. Heilmann L; Kruck M; Schindler AE Geburtshilfe Frauenheilkd; 1989 Sep; 49(9):803-7. PubMed ID: 2553528 [TBL] [Abstract][Full Text] [Related]
20. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination. Perhoniemi V; Vuorinen J; Myllynen P; Kivioja A; Lindevall K Ann Chir Gynaecol; 1996; 85(4):359-63. PubMed ID: 9014067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]